TEMPO-2 Trial
TEMPO-2 is a randomized controlled trial of TNK-tPA versus
Standard of Care for minor ischemic stroke
with proven occlusion.
For more information about the trial, contact:
TEMPO-2 Coordinating Centre
Room C1241B
1403-29th Street NW
Foothills Medical Centre
403-944-4286
Trial Site Participants
Please contact the trial office for access to documents and resources.
More aggressive drug therapy may offer better outcomes for minor stroke patients, investigators say. Click image to read the UToday article.
